Ankara Bilkent City Hospital Physical Treatment and Rehabilitation Hospital
Ankara, Turkey (Türkiye)
NCT Number: NCT05997251
The aim of this study is to reveal the relationship of DASH and Mediterranean diet score with anthropometric measurements and serum adiponectin level in individuals with spinal cord injury. This research was planned as a cross-sectional, case-control study. With the data to be obtained from the research, information will be obtained about the hormonal or biochemical basis of metabolic disorders such as atherosclerosis and insulin resistance that may occur in individuals with spinal cord injury in the long term.
20 individuals with Spinal Cord Injury will be included in the study, and the results of the patients will be compared with 20 healthy individuals. In order to determine the food consumption status of the patients, a 1-day food consumption record will be requested. DASH diet score and Mediterranean diet score will be calculated from dietary records. After 8 hours of fasting, 3 ml of peripheral blood will be taken for the measurement of adiponectin between 08:00 and 09:00 in the morning from the individuals in the study and control groups. Adiponectin level will be measured and its correlation with DASH diet score and Mediterranean diet score will be examined.
Looking for future studies?
Notify Me18 year–65 year
All sexes
Observational
Ankara, Turkey (Türkiye)
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Exclusion criteria
(Control group)
Checking and receiving the 1-day food consumption record recorded by the patient by the researcher
Adiponectin level will be measured for each group
Time frame: Will be measured at inclusion
Adiponectin level will be measured from peripheral blood
Time frame: Will be measured at inclusion from one day dietary record
Will be measured at inclusion from one day dietary record
Time frame: Will be measured at inclusion from one day dietary record
Will be measured at inclusion from one day dietary record
Time frame: Will be measured at inclusion
Will be measured at inclusion
Time frame: Will be measured at inclusion
Will be measured at inclusion
Time frame: Will be measured at inclusion
Will be measured at inclusion
Time frame: Will be measured at inclusion
Will be measured at inclusion
Time frame: Will be measured at inclusion
Will be measured at inclusion
Time frame: Will be measured at inclusion
Will be measured at inclusion
Ankara City Hospital Bilkent
Other
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT05589402
Bone Diseases, Brain Diseases
Harlingen, Texas, United States
View Trial DetailsNCT04350359
Central Nervous System Diseases, Female Urogenital Diseases
Washington D.C., District of Columbia, United States
View Trial DetailsNCT05822297
Central Nervous System Diseases, Cognition Disorders
Maastricht, Limburg, Netherlands
View Trial DetailsNCT04736849
Central Nervous System Diseases, Nervous System Diseases
Rochester, Minnesota, United States
View Trial Details